Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital-Reference-Cited by-同舟云学术

Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital

Published:2010-10 Issue:10 Volume:54 Page:4503-4505
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

DeRyke C. Andrew¹,Crawford Amanda J.²,Uddin Nizam³,Wallace Mark R.⁴

Affiliation:

1. Department of Pharmacy, Orlando Health, Orlando, Florida

2. Department of Epidemiology and Biostatistics, University of Florida, Gainesville, Florida

3. Department of Statistics, University of Central Florida, Orlando, Florida

4. Division of Infectious Diseases, Orlando Health, Orlando, Florida

Abstract

ABSTRACT Thirty adult patients who received intravenous colistin (5.1 ± 2.4 mg/kg/day) were reviewed to evaluate dosing with respect to nephrotoxicity, which occurred in 10 (33%) patients within the first 5 days of treatment. Excessive colistin dosing was frequent (47%), often (71%) resulted from the use of actual body weight in obese patients, and was associated with higher rates of nephrotoxicity (80% versus 30%, P = 0.019).

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01707-09

Reference19 articles.

1. Prediction of Creatinine Clearance from Serum Creatinine

2. Devine, B. 1974. Gentamicin therapy. Drug Intell. Clin. Pharm.8:650-655.

3. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother.33:960-967.

4. Falagas, M. E., K. N. Fragoulis, S. K. Kasiakou, G. J. Sermaidis, and A. Michalopoulos. 2005. Nephrotoxicity of intravenous colistin: a prospective evaluation. Int. J. Antimicrob. Agents26:504-507.

5. Falagas, M. E., S. K. Kasiakou, D. P. Kofteridis, G. Roditakis, and G. Samonis. 2006. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis.25:596-599.

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment;Laboratory Medicine;2023-10-26

2. Nephrotoxicity caused by colistin use in ICU: a single centre experience;BMC Nephrology;2023-10-13

3. Colistin treatment in older adults: why should we know more?;Current Medical Research and Opinion;2023-10-06

4. Secondary bacterial infections & extensively drug-resistant bacteria among COVID-19 hospitalized patients at the University Hospital in Kraków;Annals of Clinical Microbiology and Antimicrobials;2023-08-24

5. Abrupt increased serum creatinine in a hyperferritinemia patient treated with deferoxamine after cord blood transplantation: a case report with literature review;Journal of Pharmaceutical Health Care and Sciences;2023-06-01